Emerging therapeutic uses of direct‐acting oral anticoagulants: An evidence‐based perspective
@article{Raschi2017EmergingTU, title={Emerging therapeutic uses of direct‐acting oral anticoagulants: An evidence‐based perspective}, author={E. Raschi and M. Bianchin and R. De Ponti and F. De Ponti and W. Ageno}, journal={Pharmacological Research}, year={2017}, volume={120}, pages={206–218} }
&NA; Direct‐acting oral anticoagulants (DOACs) were claimed to cause a potential paradigm shift in the therapeutic scenario of patients requiring short‐ and long‐term anticoagulation, by virtue of their pharmacological properties, perceived as innovative. The evidence gathered so far (from pre‐approval pivotal trials to real‐world post‐marketing observational data) consistently confirmed that DOACs are overall comparable to vitamin‐K antagonists (VKAs) in terms of safety, efficacy and… CONTINUE READING
9 Citations
Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon?
- Medicine
- Internal and Emergency Medicine
- 2017
- 4
Pharmacokinetic drug interactions of the non‐vitamin K antagonist oral anticoagulants (NOACs)
- Medicine
- Pharmacological research
- 2018
- 29
Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews
- Medicine
- Drug Safety
- 2019
- 6
Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review
- Medicine
- Clinical Drug Investigation
- 2020
- PDF
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations
- Medicine
- Internal and Emergency Medicine
- 2017
- 12
Dosing considerations in the use of the direct oral anticoagulants in the antiphospholipid syndrome
- Medicine
- Journal of clinical pharmacy and therapeutics
- 2018
- 7
Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation
- Medicine
- Pharmacological research
- 2018
- 6
References
SHOWING 1-10 OF 101 REFERENCES
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
- Medicine
- Drug Safety
- 2016
- 19
Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications.
- Medicine
- Polskie Archiwum Medycyny Wewnetrznej
- 2016
- 16
- PDF
Direct oral anticoagulants: Current indications and unmet needs in the treatment of venous thromboembolism
- Medicine
- Pharmacological research
- 2017
- 22
Meta‐analysis of the efficacy and safety of new oral anticoagulants in patients with cancer‐associated acute venous thromboembolism: comment
- Medicine
- Journal of thrombosis and haemostasis : JTH
- 2014
- 104
Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants.
- Medicine
- Circulation research
- 2016
- 65
- PDF
Efficacy and safety of anticoagulant therapy for the treatment of acute cancer-associated thrombosis: a systematic review and meta-analysis.
- Medicine
- Thrombosis research
- 2014
- 116
Current Clinical Trials on the Use of Direct Oral Anticoagulants in the Pediatric Population
- Medicine
- Cardiology and Therapy
- 2016
- 33
- PDF
Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes
- Medicine
- PloS one
- 2014
- 47
- PDF
Novel oral anticoagulants for heparin-induced thrombocytopenia
- Medicine
- Journal of Thrombosis and Thrombolysis
- 2016
- 22
Italian intersociety consensus on DOAC use in internal medicine
- Medicine
- Internal and Emergency Medicine
- 2017
- 38
- PDF